658MO Cisplatin (cis)-related immunomodulation and efficacy with atezolizumab (atezo) + cis- vs carboplatin (carbo)-based chemotherapy (chemo) in metastatic urothelial cancer (mUC)
Authors:
- GalskyGAGalsky
- X. GuanXGX. Guan
- R. BanchereauRBR. Banchereau
- L. WangLWL. Wang
- J. ZhuJZJ. Zhu
- H. YuHYH. Yu
- D. RishipathakDRD. Rishipathak
- E. HajajEHE. Hajaj
- R.H. HerbstRHR.H. Herbst
- I.D. DavisIDI.D. Davis
- E. GrandeEGE. Grande
- A. BamiasABA. Bamias
- 1 September 2021
- journal article
- abstracts
- Published by Elsevier in Annals of Oncology
- Vol. 32, S682-S683
Abstract
No abstract availableFunding Information
- F. Hoffmann-La Roche